🔬 Premier centre européen dédié aux maladies génétiques.
📍 Campus Necker - Enfants Malades, Paris | #Recherche #Santé #Innovation
🌐 www.institutimagine.org
Institut Imagine
Loading...
🧬 Happening now: Prof. Yenan Bryceson (Karolinska Institutet) is presenting today's Monday Seminar at Imagine.
He's discussing the "Regulation of flexibility in T cell signaling," exploring the biology of cytotoxic T cells to better understand primary immunodeficiencies & develop cancer therapies.
Studying cancer avoidance isn’t straightforward.
It means finding individuals who don’t develop cancer, and analysing them at scale.
That level of research needs global collaboration, and Cancer Grand Challenges makes it possible.
Read about this work ➡️ www.technologynetworks.com/cancer-resea...
Juliette Leon (INEM) closes the seminar with anti-HLA desensitization strategies in organ transplantation. These approaches are essential to lower the risk of rejection and improve graft survival. 🫀🏥 #Transplant #Immunology
Brigitte Bader-Meunier (Hôpital Necker) discusses anti-interferon therapeutic antibodies in pediatric dermatomyositis. A crucial step forward to better treat this rare autoimmune disease in children! 🧒💊 #RareDiseases #Immunology
Sandrine Moutel (@institutcurie.bsky.social) opens the session on the role of antibodies in oncology. These targeted therapies have become essential for specifically identifying and attacking tumor cells to better fight cancer. 🔬 #Oncology
Live from Institut Imagine for the MAGIC seminar! 🧬 Today, we're exploring major advances in therapeutic antibodies and immunology with 4 experts. Follow this thread for key takeaways from the presentations. ⬇️
STAT2 R148 variant: A 16th-century founder mutation and clinical response to high-dose JAK inhibitor therapy. New study from Nima Parvaneh (Tehran University of Medical Sciences), Jacinta Bustamante @institutimagine.bsky.social and colleagues:
rupress.org/jhi/article/...
#Autoinflammation #IEIs
Wrapping up Monday with some fantastic science! 👏
Earlier today, we had the pleasure of hosting Dr. Enzo Poirier (Institut Curie) for our #MondaySeminar.
Huge thanks to him for sharing his work on engineering immunotherapies by harnessing the conservation of immunity. 🧬
Lucienne Chatenoud (INEM) presents the use of non-mitogenic anti-CD3 antibodies in type 1 diabetes. The goal? Modulating the immune response to protect the pancreas and slow disease progression. 🩸 #Diabetes #Immunotherapy
🧠 What makes the human brain uniquely... human?
That's the question at the heart of a study just published in @nature.com by Denis Jabaudon, Esther Klingler, and their teams.
📄 Javed, Gómez et al., Nature (2026) — DOI: lnkd.in/eF_mH72U
